Concepts (106)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Osteitis Deformans | 2 | 2023 | 54 | 1.760 |
Why?
|
Acarbose | 2 | 2020 | 10 | 0.900 |
Why?
|
Nelson Syndrome | 1 | 2023 | 20 | 0.870 |
Why?
|
Gallium Radioisotopes | 1 | 2024 | 194 | 0.870 |
Why?
|
Receptors, Somatostatin | 1 | 2024 | 135 | 0.860 |
Why?
|
Prostatic Diseases | 1 | 2021 | 57 | 0.740 |
Why?
|
Klebsiella Infections | 1 | 2021 | 147 | 0.670 |
Why?
|
Carbamates | 2 | 2020 | 192 | 0.660 |
Why?
|
Klebsiella pneumoniae | 1 | 2021 | 255 | 0.640 |
Why?
|
Hypothermia | 1 | 2020 | 188 | 0.620 |
Why?
|
Bradycardia | 1 | 2020 | 298 | 0.620 |
Why?
|
Prednisone | 2 | 2013 | 1562 | 0.590 |
Why?
|
Hip Dislocation, Congenital | 1 | 2020 | 223 | 0.590 |
Why?
|
Urinary Tract Infections | 1 | 2024 | 816 | 0.580 |
Why?
|
Abscess | 1 | 2021 | 605 | 0.570 |
Why?
|
Thyroid Gland | 1 | 2024 | 1169 | 0.570 |
Why?
|
Prostatic Hyperplasia | 1 | 2021 | 526 | 0.560 |
Why?
|
Hyperglycemia | 2 | 2020 | 1378 | 0.540 |
Why?
|
Adenocarcinoma | 2 | 2023 | 6311 | 0.510 |
Why?
|
Graves Disease | 2 | 2013 | 239 | 0.480 |
Why?
|
Diabetes Mellitus, Type 2 | 5 | 2024 | 12268 | 0.480 |
Why?
|
Horner Syndrome | 2 | 2011 | 36 | 0.450 |
Why?
|
Antibodies, Heterophile | 1 | 2013 | 128 | 0.440 |
Why?
|
Hypoglycemic Agents | 4 | 2024 | 3150 | 0.420 |
Why?
|
Hashimoto Disease | 1 | 2013 | 104 | 0.410 |
Why?
|
Piperidines | 2 | 2020 | 1649 | 0.400 |
Why?
|
Thyroid Neoplasms | 2 | 2024 | 2329 | 0.400 |
Why?
|
Gynecomastia | 1 | 2011 | 87 | 0.370 |
Why?
|
Thyrotropin | 1 | 2013 | 832 | 0.340 |
Why?
|
Glucocorticoids | 2 | 2020 | 2142 | 0.320 |
Why?
|
Pupil Disorders | 1 | 2008 | 32 | 0.310 |
Why?
|
Heart | 1 | 2020 | 4390 | 0.280 |
Why?
|
Electrocardiography | 1 | 2020 | 6400 | 0.270 |
Why?
|
Diabetic Neuropathies | 1 | 2008 | 406 | 0.240 |
Why?
|
Ethanol | 1 | 2011 | 1314 | 0.240 |
Why?
|
Thyroid Nodule | 1 | 2011 | 760 | 0.220 |
Why?
|
Adrenocortical Carcinoma | 1 | 2023 | 86 | 0.210 |
Why?
|
Bone and Bones | 2 | 2023 | 2560 | 0.210 |
Why?
|
Adrenal Cortex Neoplasms | 1 | 2023 | 159 | 0.200 |
Why?
|
Blood Glucose | 3 | 2020 | 6368 | 0.190 |
Why?
|
Pregnenediones | 1 | 2020 | 29 | 0.190 |
Why?
|
Organometallic Compounds | 1 | 2024 | 660 | 0.180 |
Why?
|
Ceftriaxone | 1 | 2021 | 175 | 0.170 |
Why?
|
Rewarming | 1 | 2020 | 64 | 0.170 |
Why?
|
Clonidine | 2 | 2011 | 170 | 0.160 |
Why?
|
Kallmann Syndrome | 1 | 2019 | 139 | 0.160 |
Why?
|
Iran | 2 | 2020 | 733 | 0.150 |
Why?
|
Muscular Dystrophy, Duchenne | 1 | 2020 | 268 | 0.150 |
Why?
|
Ventricular Fibrillation | 1 | 2020 | 539 | 0.140 |
Why?
|
Radiopharmaceuticals | 1 | 2024 | 2630 | 0.120 |
Why?
|
Humans | 20 | 2024 | 759255 | 0.110 |
Why?
|
Hip Joint | 1 | 2020 | 1006 | 0.110 |
Why?
|
Administration, Oral | 1 | 2021 | 4046 | 0.110 |
Why?
|
Cardiopulmonary Resuscitation | 1 | 2020 | 1001 | 0.100 |
Why?
|
Addison Disease | 1 | 2011 | 48 | 0.100 |
Why?
|
Respiratory Insufficiency | 1 | 2020 | 1225 | 0.090 |
Why?
|
Adrenal Hyperplasia, Congenital | 1 | 2011 | 102 | 0.090 |
Why?
|
Anti-Inflammatory Agents | 1 | 2020 | 1799 | 0.090 |
Why?
|
Heart Arrest | 1 | 2020 | 1503 | 0.090 |
Why?
|
Recovery of Function | 1 | 2020 | 2979 | 0.080 |
Why?
|
Anisocoria | 1 | 2008 | 9 | 0.080 |
Why?
|
Sympathetic Fibers, Postganglionic | 1 | 2008 | 14 | 0.080 |
Why?
|
Respiration, Artificial | 1 | 2020 | 2616 | 0.080 |
Why?
|
Neoplasms, Radiation-Induced | 1 | 2012 | 549 | 0.080 |
Why?
|
Adrenergic alpha-Agonists | 1 | 2008 | 178 | 0.070 |
Why?
|
Iris | 1 | 2008 | 231 | 0.070 |
Why?
|
Private Practice | 1 | 2008 | 153 | 0.070 |
Why?
|
Diagnostic Errors | 1 | 2013 | 1266 | 0.070 |
Why?
|
Diagnosis, Differential | 1 | 2021 | 12964 | 0.060 |
Why?
|
Nurse Practitioners | 1 | 2007 | 268 | 0.060 |
Why?
|
Female | 10 | 2020 | 390240 | 0.060 |
Why?
|
Substance-Related Disorders | 1 | 2020 | 4358 | 0.060 |
Why?
|
Adult | 7 | 2023 | 219390 | 0.050 |
Why?
|
Anti-Bacterial Agents | 1 | 2021 | 7380 | 0.050 |
Why?
|
Self Care | 1 | 2007 | 793 | 0.050 |
Why?
|
Severity of Illness Index | 1 | 2020 | 15815 | 0.050 |
Why?
|
Ki-67 Antigen | 1 | 2023 | 631 | 0.050 |
Why?
|
Metformin | 1 | 2008 | 912 | 0.050 |
Why?
|
Australia | 1 | 2023 | 1287 | 0.040 |
Why?
|
Aged | 4 | 2021 | 168617 | 0.040 |
Why?
|
Middle Aged | 6 | 2023 | 219653 | 0.040 |
Why?
|
Male | 6 | 2021 | 358719 | 0.040 |
Why?
|
Tomography, X-Ray Computed | 1 | 2021 | 20461 | 0.040 |
Why?
|
Risk Factors | 1 | 2024 | 74167 | 0.030 |
Why?
|
Androgens | 1 | 2023 | 1288 | 0.030 |
Why?
|
Hydrocortisone | 1 | 2023 | 1795 | 0.030 |
Why?
|
Extracellular Matrix Proteins | 1 | 2019 | 829 | 0.030 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2008 | 3438 | 0.030 |
Why?
|
Drug Administration Schedule | 1 | 2020 | 4898 | 0.030 |
Why?
|
Adolescent | 4 | 2012 | 87560 | 0.020 |
Why?
|
Diabetes Mellitus | 1 | 2007 | 5880 | 0.020 |
Why?
|
Iodine Radioisotopes | 1 | 2012 | 1030 | 0.020 |
Why?
|
Cholesterol, LDL | 2 | 2008 | 2417 | 0.020 |
Why?
|
Biopsy, Fine-Needle | 1 | 2012 | 1111 | 0.020 |
Why?
|
Carcinoma, Papillary | 1 | 2012 | 785 | 0.020 |
Why?
|
Nerve Tissue Proteins | 1 | 2019 | 4409 | 0.020 |
Why?
|
Lipase | 1 | 2008 | 324 | 0.020 |
Why?
|
Insulin | 1 | 2020 | 6591 | 0.020 |
Why?
|
Treatment Outcome | 2 | 2008 | 64879 | 0.020 |
Why?
|
Disease Progression | 1 | 2020 | 13479 | 0.010 |
Why?
|
Carcinoma | 1 | 2012 | 2334 | 0.010 |
Why?
|
Prospective Studies | 2 | 2020 | 54204 | 0.010 |
Why?
|
Child | 2 | 2019 | 79623 | 0.010 |
Why?
|
Mutation | 1 | 2019 | 29877 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2023 | 80121 | 0.010 |
Why?
|
Young Adult | 1 | 2008 | 58483 | 0.000 |
Why?
|
Concepts
(106)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(1)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_